Moberg Pharma AB (publ) (STO: MOB)
Sweden
· Delayed Price · Currency is SEK 9.89
+0.36 (3.78%)
Jan 20, 2025, 5:29 PM CET
Moberg Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 308.96 | 60.56 | 125.55 | 102.66 | 19.29 | 36.27 | Upgrade
|
| Cash & Short-Term Investments | 308.96 | 60.56 | 125.55 | 102.66 | 19.29 | 36.27 | Upgrade
|
| Cash Growth | 204.39% | -51.77% | 22.30% | 432.28% | -46.83% | -96.05% | Upgrade
|
| Accounts Receivable | - | - | 0.38 | 0.47 | - | 6.75 | Upgrade
|
| Other Receivables | 5.14 | 0.79 | 1.06 | 0.66 | 2.16 | - | Upgrade
|
| Receivables | 5.14 | 0.79 | 1.44 | 1.14 | 2.16 | 6.75 | Upgrade
|
| Inventory | 6.88 | 7.12 | - | - | - | - | Upgrade
|
| Prepaid Expenses | - | 0.9 | 0.72 | 0.75 | 0.85 | - | Upgrade
|
| Other Current Assets | - | 0.14 | 0.06 | 0.12 | 144.52 | - | Upgrade
|
| Total Current Assets | 320.98 | 69.49 | 127.76 | 104.66 | 166.81 | 43.02 | Upgrade
|
| Property, Plant & Equipment | 3.95 | 4.94 | 5.98 | 4.52 | 7.1 | 8.05 | Upgrade
|
| Other Intangible Assets | - | - | - | - | - | 6.85 | Upgrade
|
| Long-Term Deferred Tax Assets | 33.12 | 28.08 | 22.58 | 14.67 | 10.93 | 6.21 | Upgrade
|
| Long-Term Deferred Charges | 587.25 | 532.22 | 408.1 | 327.04 | 295.73 | 300.06 | Upgrade
|
| Total Assets | 945.32 | 634.73 | 564.42 | 450.89 | 480.58 | 364.19 | Upgrade
|
| Accounts Payable | - | 6.77 | 17.11 | 5.31 | 2.95 | - | Upgrade
|
| Accrued Expenses | - | 12.5 | 7.56 | 7.45 | 8.73 | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 5.13 | Upgrade
|
| Current Portion of Leases | 1.3 | 1.27 | 2.12 | 2.7 | 2.64 | 2.51 | Upgrade
|
| Other Current Liabilities | 12.95 | - | - | 0.09 | 65.87 | 22.27 | Upgrade
|
| Total Current Liabilities | 14.26 | 20.54 | 26.79 | 15.54 | 80.18 | 29.9 | Upgrade
|
| Long-Term Leases | 2.37 | 3.47 | 3.99 | 1.24 | 4.75 | 5.83 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Total Liabilities | 16.62 | 24.01 | 30.84 | 16.84 | 85 | 35.79 | Upgrade
|
| Common Stock | 46.69 | 27.96 | 9.83 | 4.41 | 2.09 | 1.87 | Upgrade
|
| Additional Paid-In Capital | 1,232 | 921.3 | 841.2 | 731.38 | 693.28 | 579.4 | Upgrade
|
| Retained Earnings | -350.34 | -338.53 | -317.44 | -301.73 | -309.22 | -252.87 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | 1.73 | - | Upgrade
|
| Total Common Equity | 928.7 | 610.73 | 533.58 | 434.05 | 387.87 | 328.4 | Upgrade
|
| Minority Interest | - | - | - | - | 7.71 | - | Upgrade
|
| Shareholders' Equity | 928.7 | 610.73 | 533.58 | 434.05 | 395.58 | 328.4 | Upgrade
|
| Total Liabilities & Equity | 945.32 | 634.73 | 564.42 | 450.89 | 480.58 | 364.19 | Upgrade
|
| Total Debt | 3.67 | 4.74 | 6.11 | 3.93 | 7.4 | 13.46 | Upgrade
|
| Net Cash (Debt) | 305.3 | 55.82 | 119.45 | 98.72 | 11.89 | 22.82 | Upgrade
|
| Net Cash Growth | 212.46% | -53.27% | 20.99% | 730.24% | -47.89% | -97.42% | Upgrade
|
| Net Cash Per Share | 9.21 | 3.52 | 15.74 | 22.94 | 6.28 | 12.10 | Upgrade
|
| Filing Date Shares Outstanding | 46.69 | 27.96 | 9.83 | 4.4 | 1.99 | 1.87 | Upgrade
|
| Total Common Shares Outstanding | 46.69 | 27.96 | 9.83 | 4.4 | 1.99 | 1.87 | Upgrade
|
| Working Capital | 306.73 | 48.95 | 100.97 | 89.12 | 86.63 | 13.12 | Upgrade
|
| Book Value Per Share | 19.89 | 21.84 | 54.30 | 98.54 | 195.26 | 175.59 | Upgrade
|
| Tangible Book Value | 928.7 | 610.73 | 533.58 | 434.05 | 387.87 | 321.55 | Upgrade
|
| Tangible Book Value Per Share | 19.89 | 21.84 | 54.30 | 98.54 | 195.26 | 171.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.